Patient Gateway

RSS Feed

Yifeixiaoji decoction as an adjunct to osimertinib therapy in advanced EGFR-mutated NSCLC: protocol for a randomized, double-blind, placebo-controlled trial

In silico and in vitro evaluation of synergistic anticancer effects of erucin and kaempferol from Eruca sativa against human A549 non-small cell lung cancer cells (NSCLC)

例证长存｜高危 EGFR 突变 NSCLC 的联合治疗优化：真实病例中的个体化诊疗思考_腾讯新闻

Immunotherapy plus chemotherapy improves survival in SMARCA4-deficient NSCLC: a real-world cohort study

Hutchmed (China) Says Orpathys Plus Tagrisso Improves Survival In Egfr-Mutated Nsclc In Phase III Trial

AstraZeneca and Daiichi Sankyo’s Enhertu Improves PFS in First-Line HER2-Mutant Advanced NSCLC in Phase III DESTINY-Lung04

Impact of Surgical Resection on 5-Year Survival in Elderly NSCLC Patients: A SEER Database Analysis With Machine Learning-Based Predictive Modeling in Patients Aged ≥ 60 (2000–2021)

TIGIT Combo Fails to Improve Outcomes in Stage III NSCLC

Impact of Surgical Resection on 5-Year Survival in Elderly NSCLC Patients: A SEER Database Analysis With Machine Learning-Based Predictive Modeling in Patients Aged ≥ 60 (2000–2021)

REZILIENT3 Trial: Major Positive Phase 3 Result in Exon 20 NSCLC